Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
 - Shares are not adjusted for stock split.
 
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
 - Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date  | Reported DateTime  | Exercisable Expiration  | Company | Symnbol | Insider Relationship  | Shares Traded  | Conversion Price  | Shares Owned  | Filing | 
| 2025-08-06 Option Award  | 2025-08-08 4:32 pm  | N/A N/A  | Aptevo Therapeutics Inc. | APVO | Lamothe Jeffrey G. EVP, COO  | 17,300 | $0 | 17,300 (Direct)  | View | 
| 2025-07-17 Exercise  | 2025-07-21 4:35 pm  | N/A N/A  | Aptevo Therapeutics Inc. | APVO | Lamothe Jeffrey G. EVP, COO  | 5 | $0 | 18 (Direct)  | View | 
| 2025-03-02 Exercise  | 2025-03-04 4:35 pm  | N/A N/A  | Aptevo Therapeutics Inc. | APVO | Lamothe Jeffrey G. EVP, COO  | 5 | $0 | 40 (Direct)  | View | 
| 2024-08-08 Exercise  | 2024-08-09 4:33 pm  | N/A N/A  | Aptevo Therapeutics Inc. | APVO | Lamothe Jeffrey G. EVP, COO  | 314 | $0 | 1,207 (Direct)  | View | 
| 2024-07-17 Option Award  | 2024-07-19 4:35 pm  | N/A N/A  | Aptevo Therapeutics Inc. | APVO | Lamothe Jeffrey G. EVP, COO  | 12,825 | $0 | 12,825 (Direct)  | View | 
| 2024-03-02 Exercise  | 2024-03-05 4:12 pm  | N/A N/A  | Aptevo Therapeutics Inc. | APVO | Lamothe Jeffrey G. EVP, COO  | 9,167 | $0 | 52,171 (Direct)  | View | 
| 2024-01-28 Exercise  | 2024-01-30 6:04 pm  | N/A N/A  | Aptevo Therapeutics Inc. | APVO | Lamothe Jeffrey G. EVP, COO  | 1,833 | $0 | 28,337 (Direct)  | View | 
| 2023-08-08 Exercise  | 2023-08-10 08:41 am  | N/A N/A  | Aptevo Therapeutics Inc. | APVO | Lamothe Jeffrey G. EVP, COO  | 13,812 | $0 | 42,150 (Direct)  | View | 
| 2023-03-03 Option Award  | 2023-03-07 4:44 pm  | N/A N/A  | Aptevo Therapeutics Inc. | APVO | Lamothe Jeffrey G. EVP, COO  | 33,000 | $0 | 53,026 (Direct)  | View | 
| 2023-03-03 Exercise  | 2023-03-07 4:44 pm  | N/A N/A  | Aptevo Therapeutics Inc. | APVO | Lamothe Jeffrey G. EVP, COO  | 3,666 | $0 | 53,026 (Direct)  | View | 
| 2023-01-29 Exercise  | 2023-01-30 1:04 pm  | N/A N/A  | Aptevo Therapeutics Inc. | APVO | Lamothe Jeffrey G. CFO  | 1,834 | $0 | 10,859 (Direct)  | View | 
| 2022-08-09 Option Award  | 2022-08-10 4:08 pm  | N/A N/A  | Aptevo Therapeutics Inc. | APVO | Lamothe Jeffrey G. CFO  | 34,958 | $0 | 34,958 (Direct)  | View | 
| 2022-06-07 Option Award  | 2022-06-07 5:25 pm  | N/A N/A  | Aptevo Therapeutics Inc. | APVO | Lamothe Jeffrey G. CFO  | 11,000 | $0 | 11,000 (Direct)  | View | 
| 2022-03-04 Option Award  | 2022-03-04 6:11 pm  | N/A 2032-03-03  | Aptevo Therapeutics Inc. | APVO | Lamothe Jeffrey G. CFO  | 11,000 | $0 | 11,000 (Direct)  | View | 
| 2022-01-29 Exercise  | 2022-02-01 6:00 pm  | N/A N/A  | Aptevo Therapeutics Inc. | APVO | Lamothe Jeffrey G. SVP and CFO  | 1,833 | $0 | 10,859 (Direct)  | View | 
| 2021-01-29 Option Award  | 2021-02-17 9:02 pm  | N/A 2031-01-29  | Aptevo Therapeutics Inc. | APVO | Lamothe Jeffrey G. SVP and CFO  | 22,000 | $0 | 22,000 (Direct)  | View |